The effects of graded doses of insulin and corticosterone on myofibrillar protein turnover were investigated in growing diabetic rats in order to assess their counteractive roles in the control of protein accretion. Nt-Methylhistidine excretion and carcass protein accretion were measured over 6 days in streptozotocin-diabetic rats receiving either a constant catabolic dose of corticosterone accompanied by graded doses of insulin or a constant dose of insulin accompanied by graded doses of corticosterone. The high corticosterone dose decreased the rate of protein accretion by both increasing the rate of degradation and decreasing the rate of synthesis. Increasing insulin dosage counteracted these effects, but could not restore positive accretion rates. Direct measurement of protein-synthesis rates gave results comparable with those obtained from use of Nt-methylhistidine excretion. At constant insulin dosage, increased corticosterone to 45 mg/kg body wt. per day caused a dose-related linear decrease in protein accretion rates from +4.5 to -3.2% per day. Growth ceased at 28mg of corticosterone/kg body wt. per day, largely owing to a fall in synthesis rates (-3.5%/day) rather than the increase in degradation rates ( + 1 .0%/day). However, at steroid doses greater than 30mg/kg body wt. per day the degradation rate increased markedly and accounted for most of the additional fall in accretion. These results show that insulin antagonizes the action of glucocorticoids on both the synthesis and degradative pathways of myofibrillar protein turnover. The changes in fractional degradation rates appear relatively more attenuated by insulin than are those of synthesis.
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There is considerable evidence that insulin normally exerts a tonic suppressive effect on the rate of muscle protein degradation, since these rates are increased in diabetes and returned to normal with insulin treatment (Dahlman et al., 1979; Tomas & Ballard, 1979; Tischler, 1981) . Further, insulin treatment of diabetic rats receiving a catabolic dose of corticosterone diminishes the rate of muscle protein breakdown, as assessed by N'-methylhistidine excretion (Tomas & Ballard, 1979) . The secondary rise in plasma insulin concentrations after corticosterone treatment of intact rats has also been shown to decrease the catabolic response (Tomas, 1982) . Insulin and corticosterone also have opposing effects on the rates of muscle protein synthesis. Both glucocorticoid treatment and insulin deficiency lead to a decrease in the amount of rRNA available for translation (synthetic capacity) and the rate of protein synthesis per ribosomal unit (RNA activity) (Millward et al., 1976; Rannels & Jefferson, 1980; . However, showed that the corticosterone-induced inhibition of protein synthesis, unlike the enhancement of breakdown, was not reversible by insulin.
Muscle protein synthesis appears to be more affected by glucocorticoids than is the rate of degradation Tomas, 1982) , but the relative contributions of the changes in synthesis and degradation rates to muscle protein catabolism after glucocorticoid treatment at a range of doses under controlled insulin regimes have not been studied, despite the view that the corticosterone/insulin concentration ratio is the critical determinant of the metabolic response. Thus a high energy intake when dietary protein is inadequate is thought to exacerbate the outcome of the protein deficiency, because the consequent relatively high insulin secretion would suppress glucocorticoid-induced muscle protein breakdown and decrease the availability of certain amino acids for synthesis of export proteins by the liver (Coward & Lunn, 1981 ) . Insulin therapy has also been suggested as a means of countering the cataVol. 220 bolic state tollowing trauma, which is associated with elevated glucocorticoid (and catecholamine) concentrations (Batstone et al., 1975; O'Keefe et al., 1981) . However, the degree to-which insulin can decrease the catabolic effects of glucocorticoids on muscle protein, particularly via decreasing the degradation rate, is unknown. In this study we have examined the effects of graded doses of insulin and corticosterone administration on the rates of Nt-methylhistidine excretion and carcass protein accretion and turnover in diabetic rats. Insulin decreases the effect of glucocorticoids on both breakdown and synthesis of muscle myofibrillar protein, but to a limited extent.
Materials and methods Experimental procedures
Corticosterone and streptozotocin were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A. The corticosterone was finely ground and suspended in a vehicle which contained 0.5% soluble CM-cellulose of medium viscosity Tomas, 1982 After 5-7 days the rats were transferred to individual metabolism cages and offered a diet which contained 21% (w/w) protein and was free of Nt-methylhistidine. After a further 3-4 days, daily urine was collected over a 2-3-day pretreatment period (zero-time controls) just before experimental treatments began.
Nt-Methylhistidine-excretion experiments
Two experiments were performed. For Expt. 1, rats were divided into ten groups of four rats. One group served as the untreated age control, and the others received a daily subcutaneous injection of 45 mg of corticosterone/kg body wt. in conjunction with either 0, 10, 20 (two groups), 25, 30 (two groups), 40 or 50 units of insulin/kg body wt. for 6 days. In Expt. 2, there were four groups of 10 rats which were injected daily with either 0 (age control), 15, 25 or 35mg of corticosterone/kg body wt. for 6 days. Five rats in each group received 20 and the remainder 30 units of insulin/kg body wt.
Food intake was recorded and rats were weighed daily. For each experiment, food intake for all groups was matched to that of the corticosteronetreated group that had the lowest average consumption. Daily insulin and corticosterone injections were given just before feeding, at about 10:00h. Urine was collected into containers with thymol as a preservative and stored at -20°C. Blood samples were taken on the last day of corticosterone treatment at 5 and 24 h after feeding (T5 and T24). At the end of the experiment the rats were killed by decapitation, trunk blood was collected and the liver was removed and weighed. The skin, viscera, visible fat, feet and tail were then removed, and the resulting carcass (trunk muscles and skeleton) was weighed. In Expt. 1, gastrocnemius muscles were then removed and weighed separately. For Expt. 2, the head was included in the carcass after removal of skin, brain (by suction) eyes and salivary gland tissue. The head portion contributed 13.6+0.18 (S.E.M.)% to the total carcass weight. For each experiment an extra group of diabetic control rats was killed before commencement of the experimental treatments in order to obtain estimates of initial carcass composition (zerotime control). Protein-synthesis experiment In Expt. 3, three groups of five rats were used in a similar protocol to Expt. 1. The treatments were daily injections of 0, 45 and 45mg of corticosterone/kg body wt., accompanied by injections of 15, 15 and 30 units of insulin/kg body wt., respectively. After 4 days of treatment the animals were lightly wrapped in a towel and given a constant infusion of L-[ring-2-'4C]histidine (55nmol/ml; 3.0OuCi/ml) at 0.45ml/h for 6h via a tail vein. The infusion commenced at around 09 :OOh, about 24h after the last hormone injections. On completion of the infusion, the animals were killed, blood was sampled and the gastrocnemius, soleus and extensor digitorum longus muscles were excised and quickly frozen in liquid N2. Urine was not collected from these animals during treatment.
Analytical procedures
Urine Nt-methylhistidine concentrations were determined either by a JEOL 6AH amino acid analyser (Expt. 1) as described previously or by an Auto-Analyser method (Murray et al., 1982) . Blank values in the latter method were minimized by hydrolysis of 5 ml of urine in 10% (v/v) HCl in a boiling-water bath for 1 h before loading on to columns containing 4ml of ion-exchange resin . The resin was then washed sequentially with 50 ml of 0.15 Mcitrate/phosphate buffer (pH4.5) and 50ml of glass-distilled water. The Nt-methylhistidine (but not Nt-methylhistamine) was then eluted with 9ml of 0.2M-sodium phosphate buffer, pH8.3.
Urinary urea was determined on daily samples by using Technicon Auto-Analyser method Nlc. Glucose concentrations in plasma and urine were assayed with a hexokinase method ('Glucoquant'; Boehringer Mannheim). Plasma insulin was measured with a radioimmunoassay kit (Amersham, IM78) and total plasma corticosterone was measured by a competitive protein-binding assay based on the procedures of Murphy (1967) , with charcoal-treated rat plasma as the source of binding protein. For Expt. 1, carcass fat was determined by the method of Rothwell & Stock (1979) . The non-collagen-protein content of the fat-free carcass was determined to be 159 + 2 (n = 9)mg/g. The water content of the fat-free carcass was not affected by treatment. For Expt. 2, carcass noncollagen protein was determined directly as described previously (Tomas, 1982) , except that the sarcoplasmic protein fraction was extracted with 0.05 M-potassium phosphate buffer, pH 7.4, before dilute alkali extraction. Non-collagen protein was obtained as the sum of myofibrillar and sarcoplasmic fractions.
For Expt. 3, tissue bound and free concentrations of histidine were determined after decarboxylation and subsequent fluorimetric determination of histamine by an automated adaptation of the method of HAkanson et al. (1972) . Radioactivity was counted on a Searle 6892 counter with Picofluor-30 (Packard) as the scintillant. Calculation of myofibrillar protein breakdown and synthesis rates
The calculation of myofibrillar protein breakdown and synthesis rates from the rates of urinary Nt-methylhistidine excretion and mean carcass non-collagen-protein content was essentially as described by Tomas (1982) , with 75% of excreted Nt-methylhistidine assumed to arise from skeletal muscle. The initial non-collagen-protein content of the carcass was based on the carcass composition of the relevant group killed before treatment. The body composition of these diabetic rats, relative to body weight, remained constant in the bodyweight range 125-150g. It was necessary to use weight-adjusted initial control data because of the difficulty of achieving uniform weight for age groups with diabetic rats. The Nt-methylhistidine content of total carcass non-collagen protein (as distinct from hind-leg muscle) in seven samples pooled from 28 rats was determined to be 3.50+0.06pmol/g. Thus the fractional degradation rate of carcass non-collagen protein (%/day) is calculated as follows:
NT_Methylhistidine (,umol/day) x 0.75 x 100 non-collagen-protein (g) x 3.50 (,umol/g) The myofibrillar fraction of the non-collagen protein was 70.8 ±0.4o% (n = 18) and was not affected by corticosterone treatment, at least up to 35mg/kg body wt. per day (Expt. 2). Thus noncollagen-protein turnover rates as determined here are the same as for the myofibrillar protein, from which the Nt-methylhistidine excretion largely derives. The accretion and degradation rates calculated from Nt-methylhistidine excretion are the integrated average over 6 days of collection and do not show between-and within-day variations. Thus the calculated synthesis rates are also an integrated 6-day average, and changes caused by treatment may follow a time course different from the other components of protein turnover.
In Expt. 3, protein synthesis rates for gastrocnemius, soleus and extensor digitorum longus muscles were calculated from the specific-radioactivity ratio of protein-bound to free intracellular histidine (Garlick et al., 1973) by using factors in the equation appropriate to histidine. Protein accretion was determined from-the average change in muscle protein content over the 4 days of treatment and the average rate of protein breakdown determined by difference.
Stastical analysis
All results are presented as means+ S.E.M., with numbers of observations in parentheses. The results were analysed statistically by using standard methods for determination of Student's t values and analysis of variance (Snedecor & Cochran, 1967) . Simultaneous multiple comparisons were made by using modified t-statistics according to the Bonferroni method (Wallenstein et al., 1980) . Because of the cumulative assumptions used in deriving either synthesis (Expts. 1 and 2) or degradation (Expt. 3) rates by difference, the average values shown are considered to be largely qualitative, and no stastical analysis was made on these data. Results
Nt-Methylhistidine experiments
Food intake, body and organ weights. The effect on body and organ weights of increasing insulin administration to diabetic rats receiving 45mg of corticosterone/kg per day is shown in (Table 2) to negative rates at the highest dose. Corticosterone also significantly increased the weight of the liver relative to body weight, but there was no effect on relative carcass non-collagen-protein mass. Food intake was controlled to match those of the treated rats in Expt. 1 and was not affected by treatment. Although the higher dose rate of insulin tended to diminish the effects of the corticosteroid, the differences were not significant. For clarity, data from the two insulin-treatment groups in this experiment have been combined for statistical analysis in Table 2 (Fig. 2) . This relationship was more pronounced in the plasma samples taken 5 h rather than 24 h after injection, when concentrations of corticosterone and insulin were substantially higher. Glucose concentrations at qkh corticosterone dosage rate were substantially ldwer 5 h after injection and reflected the boosted insulin concentrations at this time. However, all rats, including the control group not receiving corticosterone, were hyperglycaemic 24h after insulin injection. Initial control values in diabetic rats receiving 15 units of insulin/kg per day were 171 +30ng/ml, 0.82-+ 0.2ng/ml and 28.5+1.2mM for corticosterone, insulin and glucose, respectively. These concentrations are similar to those of the age controls in Expt. 1 which received the same dose of insulin, but differ from those of the age Corticosterone dose (mg/kg body wt. per day) Fig. 3 . Corticosterone treatment increased N'-methylhistidine excretion per unit body weight in a dose-related manner (Fig. 3b) , but the extent of the rise was inversely proportional to the dose of insulin (Fig. 3a) . Thus for rats receiving 45mg of corticosterone/kg for 6 days, total Nrmethylhistidine excretion increased by 75% above control rates when 10 units of insulin/kg was given, but only by about 25% when 40-50 units of insulin/kg was given. There is no apparent reason for the difference in the control values between the two experiments, but insulin dosage and the degree of induced diabetes are obvious considerations. Urea-N excretion, expressed as a proportion of nitrogen intake, was increased progressively by corticosterone treatment (Fig. 3b) Although the increase in the rate of breakdown was decreased to almost half the observed maximum by added insulin, the accretion and synthesis rates recovered only one-third and one-quarter of their respective decline. In terms of fractional turnover, increasing insulin dosage from 10 to 30 or more units/kg body wt. per day decreased the breakdown rate by 1.5% per day and increased accretion and synthesis rates by 3.0 and 1.5% per day respectively. Thus the improvement in accretion rate arose about equally from changes in synthesis and degradation rates.
The effect of varying the corticosterone dosage while holding insulin constant at either 20 or 30 units/kg per day is shown in Fig. 5 , which contains data from both Expts. 1 and 2. The carcass non-collagen-protein accretion rate was inversely related to the corticosterone dose. The relationship was virtually linear (y = 0.172x+4.79, S.,, = 0.17; r = -0.91, n = 52) where y is the accretion rate (% per day) and x is the dose rate of corticosterone (mg/kg body wt. per day) with zero accretion (growth stasis) occurring at a dose rate of about 28mg of corticosterone/kg body wt. per day.
Degradation fibrillar protein determined in Expt. 1 from NTmethylhistidine excretion.
Discussion
Our data clearly show that glucocorticoid administration to growing diabetic rats led to a marked loss of muscle protein, owing to reciprocal changes in the rates of myofibrillar protein synthesis and degradation (Expts. 1 and 3). In agreement with the findings of other workers al., 1983) , gluco- corticoid treatment appeared to alter synthesis rates more than degradation rates. Only about 35% of the change in accretion was accounted for by the change in degradation. However, the contribution from increased degradation rates rose with higher dose rates (Fig. 5; Odedra et al., 1983) .
Experiments on incubated muscle and perfused hindquarter indicate that effects on muscle protein degradation are of little, if any, importance in the response to glucocorticoids (Shoji & Pennington, 1977; McGrath & Goldspink, 1980; Rannels & Jefferson, 1980; Kelly & Goldspink, 1982) . However, these observations were usually made at only a single rate of administration of glucocorticoid, and no attempt was made to examine the possibility of a different dose effect on synthesis and and Odedra et al. (1980) extended the earlier findings of and showed that the relative effects of glucocorticoid on synthesis and degradation processes were indeed dose-dependent. Synthesis rates were slowed at relatively low dosage, but the breakdown rate (determined by difference from synthesis and accretion rates) increased only at higher doses of glucocorticoid. This agrees with the Nt-methylhistidine-excretion data presented here and previously Santidrian et al., 1981) . The differing sensitivity of the synthesis and degradative processes in the muscle protein is clearly seen in the results of Expt. 2. The fall in the protein accretion rate from 4.5 to around 0.0% per day after corticosterone dosage was accomplished almost entirely by an apparent decrease in synthesis rates. However, when glucocorticoid dosage caused loss of non-collagen-protein mass, there was a marked increase in the rate of breakdown which contributed most to the change in accretion at negative growth rates. Thus it appears that only where net protein loss occurs in response to corticosterone treatment is there a marked increase in muscle protein breakdown. This agrees with the findings of others, where degradation was determined by the difference between measured rates of synthesis and accretion (Odedra et al., 1980 (Odedra et al., , 1983 or by Nt-methylhistidine excretion . On the other hand, these data indicate that protein-synthesis rates are most affected within the range of corticosterone dosage required to produce growth stasis and illustrate how protein accretion can be sensitively regulated, at least in rapidly growing animals. This has been pointed out by other workers (Rannels & Jefferson, 1980; , but it must be recognized that the relationships shown here need not apply in mature animals, where growth is not present.
Our finding that insulin can reverse the effects of corticosterone on muscle protein turnover ( Fig. 4 ; Table 3 ), albeit only partially, supports our earlier results (Tomas, 1982) but does not agree with the findings of others. injected diabetic rats with 50mg of corticosterone/kg body wt. per day, but could not demonstrate any reversal by insulin of glucocorticoid inhibition of muscle protein synthesis. However, their insulin doses ranged only from 0.6 to 1.2 units/day (about 4-10 units/kg body wt. per day, delivered continuously), which were at the lower end of the range used here. Indeed, the circulating concentrations of insulin maintained by the rats reported by were only about onethird of the concentration found in non-diabetic rats injected with the same amount of cortico- Tomas, 1982) . It could be argued that unless circulating insulin concentrations reached at least the high values that occur in response to glucocorticoid injection (Millward et al., 1975; Tomas, 1982) , and which presumably reflect insulin resistance (possibly owing to receptor down-regulation), then little if any reversal of the glucocorticoid action could be expected. In Expt. 1 plasma samples were obtained 24h after injection (Fig. 1) . On the basis of the samples taken 5 h after injection in Expt. 2 (Fig. 2) , substantially higher insulin concentrations of 5-20ng/ml would probably have been present during a large part of the day.
Nitrogen balances were not measured in these experiments, but the urea-N excretion, expressed relative to dietary N intake, provides an index of net protein utilization and balance. Increased insulin administration did not significantly decrease the loss of dietary N as urea, even though there was a substantial decrease in Nt-methylhistidine excretion (Fig. 3a) . This probably reflects the relatively small contribution of muscle protein breakdown to the total N flux in the rat. A 10% increment in muscle protein breakdown is only equivalent to about 3% of protein intake. On the other hand, urea excretion is stimulated to a greater extent than Nt-methylhistidine excretion at the lower dose rates of corticosterone (Fig. 3b) . Thus urea-N excretion was increased by 27, 40, 52 and 72% above baseline by 15, 25, 35 and 45mg of corticosterone/kg body wt. per day, compared with 6, 27, 44 and 87%, respectively, for Nt-methylhistidine excretion. This supports the notion that an increase in the rate of muscle protein breakdown (as distinct from muscle protein loss) is at first a relatively minor component of the overall catabolic response to increasing circulating concentrations of glucocorticoids.
The validity of the use of Nt-methylhistidine as a measure of myofibrillar protein degradation remains controversial Bates & Millward, 1981; Cotellessa et al., 1983) . We have discussed previously the various considerations and assumptions used in this paper (Tomas, 1982; Tomas et al., 1984) . The most likely source of error would appear to be the contribution to Ntmethylhistidine excretion by gut serosal protein turnover (Wassner & Li, 1982; Cotellessa et al., 1983; . Kelly & Goldspink (1982) found no change in the fractional synthesis rate of proteins in the intestinal serosa after treatment of rats with dexamethasone at a dose equivalent to 100mg of corticosterone/kg body wt. (more than twice the highest dose rate used in our experiments), but the protein mass declined on average by 9.5% per day over 5 days, with a fall of 15% on the first day. Thus, at worst, the extra Ntmethylhistidine released could be as much as 10% of gut pool per day (on average), or about 0.1 I mol/day for a 100g rat Wassner & Li, 1982) , much less than the observed increment reported here. The data of Hillgartner et al. (1982) provide empirical evidence that Ntmethylhistidine excretion reflects myofibrillar protein breakdown in the perfused hemicorpus, since the difference between the rate of degradation determined from Nr-methylhistidine excretion and the rate of synthesis determined from phenylalanine incorporation was close to the fractional growth rate of the rat. Our direct measurements of protein synthesis reported here (Expt. 3, Table 3 ) manifestly support and agree with the findings based on the Nt-methylhistidine data. In other experiments we have found the average rate of degradation determined from Nt-methylhistidine excretion and carcass analysis to correlate well with those calculated by difference after measurement of the rate of synthesis (Garlick et al., 1980) in the total carcass muscle of the same groups of rats (r = 0.98 for group means, n = 4). Furthermore, average rates of synthesis calculated from the Nt-methylhistidine data correlated strongly with myofibrillar protein synthesis rates determined directly as above (r = 0.95, n = 32) (F. M. Tomas & L. M. Jones, unpublished work). Importantly, we have not yet found the Nt-methylhistidine excretion method to overestimate the average breakdown rate of myofibrillar protein calculated indirectly from protein synthesis measurement, and variability is much lower. Thus we consider that the calculated rates of muscle protein turnover based on our measurements adequately reflect any changes induced by the experimental treatments. This view is supported by the data of Odedra et al. (1983) , who found Nt-methylhistidine excretion by glucocorticoid-treated rats to reflect calculated rates of protein degradation in muscle.
Neither method can adequately resolve the temporal changes in synthesis and breakdown rates in response to treatment (Odedra et al., 1983) , but at least the rate of Nt-methylhistidine excretion allows an estimate of the overall integrated average rates of turnover. However, in view of the several assumptions involved in the calculations and the difficulties inherent in the estimation of changes in body composition, more emphasis should be placed on the comparative rather than quantitative aspects of the calculated protein-turnover data, especially in regard to the fractional synthesis rates of myofibrillar protein. This is consistent with the approach used previously by us and others to similar data Burini et al., 1981; Dunn et al., 1982; Tomas et al., 1984) and also allows for the fact that different muscles are affected differently by glucocorticoids Kelly & Goldspink, 1982 ; Table 3 of this paper).
These experiments show that myofibrillar protein synthesis is more sensitive to glucocorticoids than is degradation. It follows that the latter process would be proportionately more readily reversible by insulin, and this seems to be the case. However, the insulin effects appear to depend on the dose of glucocorticoids. Other factors, such as nutrient supply, growth potential and type of muscle, also influence the nature of the interaction (Griffin & Wildenthal, 1978; Goldberg et al., 1980; Tischler, 1981) and indicate that the importance of the corticosterone/insulin ratio as a regulator of protein accumulation may diminish with increasing concentrations of corticosterone.
The antagonistic effects of insulin to glucocorticoid action shown here lends further support for the traditional view of the development of kwashiorkor. In children who consume diets providing adequate energy, but insufficient protein (Coward & Lunn, 1981; Lunn & Austin, 1983) , the consequent higher rates of insulin secretion are believed to limit the availability of essential amino acids for synthesis of export proteins by the liver, thus leading to hypoalbuminaemia. Our data show that this general response may still occur despite an elevation in circulating glucocorticoid concentrations. However, more studies are needed to define the interactions at relatively low hormone concentrations and with different diets.
